TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 23 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -66.7% | 35,900 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | -45.5% | 35,900 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | +83.3% | 35,900 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | -90.3% | 35,900 | 0.0% | 0.00% | – |
| Q4 2015 | $62,000 | -7.5% | 35,900 | 0.0% | 0.00% | – |
| Q3 2015 | $67,000 | -20.2% | 35,900 | 0.0% | 0.00% | – |
| Q2 2015 | $84,000 | -59.0% | 35,900 | 0.0% | 0.00% | – |
| Q1 2015 | $205,000 | 0.0% | 35,900 | 0.0% | 0.00% | – |
| Q4 2014 | $205,000 | +37.6% | 35,900 | 0.0% | 0.00% | – |
| Q3 2014 | $149,000 | -29.4% | 35,900 | 0.0% | 0.00% | – |
| Q2 2014 | $211,000 | +2.9% | 35,900 | +18.6% | 0.00% | – |
| Q1 2014 | $205,000 | -38.1% | 30,282 | -24.8% | 0.00% | – |
| Q4 2013 | $331,000 | – | 40,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 4,644,705 | $19,322,000 | 7.71% |
| First Washington CORP | 185,250 | $771,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 194,200 | $808,000 | 0.10% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 286,801 | $1,173,000 | 0.05% |
| EMERALD ADVISERS, LLC | 175,000 | $728,000 | 0.04% |
| Pine River Capital Management L.P. | 209,900 | $873,000 | 0.01% |
| Alyeska Investment Group, L.P. | 79,196 | $329,000 | 0.01% |
| HighTower Advisors, LLC | 66,514 | $277,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,441 | $6,000 | 0.00% |
| First Eagle Investment Management, LLC | 114,456 | $476,000 | 0.00% |